Centene Corp (CNC) 68.50 $CNC Aetna (AET) Tops Q2

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2016 at 1:03 PM

Centene Corp (CNC) 68.50 $CNC

Aetna (AET) Tops Q2 Earnings & Revenues, Guides for 2016
Zacks Equity Research - Zacks Investment Research - 2 hrs 20 mins ago
Aetna's (AET) earnings upside was driven by higher fees and other revenue in Aetna's Health Care segment and lower in general and administrative expenses.
CNC: 68.50 (-0.94), ANTM: 126.25 (-1.36), UNH: 142.86 (-0.65), AET: 115.63 (+1.18)

Cigna (CI) Narrows 2016 Guidance After Q2 Earnings Miss
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 10:18AM CDT
Cigna (CI) missed the estimates due to poor performance from its Global Disability and Life segment.
CNC: 68.48 (-0.96), CI: 125.24 (-1.55), ANTM: 126.25 (-1.36), UNH: 142.86 (-0.65)

Is Centene Corp. (CNC) a Great Growth Stock?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:43AM CDT
Centene Corp. can captivate investors' attention and produce gains, being well positioned for future earnings growth
CNC: 68.48 (-0.96)

Gilead Sciences and McDonald's slip; Texas Instruments rises
AP - Tue Jul 26, 3:32PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:
CNC: 68.48 (-0.96), CE: 62.38 (-0.50), GILD: 80.18 (-0.28), TXN: 68.83 (-1.05), LVS: 49.75 (-0.49), SIRI: 4.23 (-0.11)

After Yesterday's Decline of 10.10%, Centene Offers Investors Better Value
Comtex SmarTrend(R) - Tue Jul 26, 11:57AM CDT
Centene (NYSE:CNC) traded in a range yesterday that spanned from a low of $63.44 to a high of $72.49. Yesterday, the shares fell 10.1%, which took the trading range below the 3-day low of $71.98 on volume of 8.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CNC: 68.48 (-0.96)

Centene Corporation Reports 2016 Second Quarter Results
PR Newswire - Tue Jul 26, 5:00AM CDT
Centene Corporation (NYSE: CNC) today announced its financial results for the second quarter ended June 30, 2016. The following discussions, with the exception of cash flow information, are in the context of continuing operations.
CNC: 68.48 (-0.96)

Will UnitedHealth (UNH) Continue to Beat on Earnings in Q2?
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 10:14AM CDT
UnitedHealth (UNH) will report second-quarter results on Jul 19, our proven model does not conclusively show that it will likely beat the Zacks Consensus Estimate.
CNC: 68.48 (-0.96), GILD: 80.18 (-0.28), UNH: 142.86 (-0.65), AFL: 71.36 (-0.22)

Molina Improves Operation With VCE Vblock and all-flash
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 9:26AM CDT
Molina Healthcare Inc. (MOH) is upgrading its data center with VCE Vblock System 740s converged infrastructure and the added power of all-flash.
CNC: 68.48 (-0.96), WCG: 109.08 (+2.20), SEM: 10.93 (-0.34), MOH: 56.75 (+0.59)

Aetna Inks Deal with Gateway Health to Form Affordable ACO
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 9:16AM CDT
Aetna Inc. (AET) recently joined forces with Gateway Health to form a commercial and product based Accountable Care Organization ("ACO"

.
CNC: 68.48 (-0.96), WCG: 109.08 (+2.20), SEM: 10.93 (-0.34), AET: 115.64 (+1.19)

Humana Drops to 52-Week Low on Doubts over Aetna Merger
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 8:19AM CDT
Humana Inc. (HUM) dropped to a 52- week low of $152.34 on regulatory concerns over its deal with Aetna Inc. (AET).
CNC: 68.48 (-0.96), WCG: 109.08 (+2.20), AET: 115.64 (+1.19), HUM: 168.93 (-2.25)

Blog Coverage WellCare Health and Centene Plan to Purchase Aetna's Assets
ACCESSWIRE - Mon Jul 11, 8:17AM CDT
LONDON, UK / ACCESSWIRE / July 11, 2016 / Active Wall St. blog coverage looks at the headline from Health insurers, WellCare Health Plans, Inc. (NYSE: WCG) and Centene Corp. (NYSE: CNC) as they made offers to purchase Medicare Advantage insurance portfolio that Aetna Inc. (NYSE: AET) may have to shed, in seeking clearance for regulatory approval for its proposed $37 billion takeover of Humana Inc. (NYSE: HUM), according to a report by Reuters. Register with us now for your free membership and blog access at:
CI: 125.24 (-1.55), CNC: 68.48 (-0.96), ANTM: 126.25 (-1.36), WCG: 109.08 (+2.20), AET: 115.64 (+1.19), HUM: 168.93 (-2.25)

U.S. Health Insurers Offer Safety Amid Volatility
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 4:43PM CDT
U.S. Health Insurers Offer Safety Amid Volatility
CI: 125.24 (-1.55), CNC: 68.48 (-0.96), ANTM: 126.25 (-1.36), UNH: 142.86 (-0.65), WCG: 109.08 (+2.20), AET: 115.64 (+1.19), MOH: 56.75 (+0.59), HUM: 168.93 (-2.25)

Health Insurance Industry Outlook - June 2016
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 3:13PM CDT
Health Insurance Industry Outlook - June 2016
CI: 125.24 (-1.55), CNC: 68.48 (-0.96), ANTM: 126.25 (-1.36), UNH: 142.86 (-0.65), WCG: 109.08 (+2.20), AET: 115.64 (+1.19), HUM: 168.93 (-2.25)

Centene's Indiana Subsidiary Selected for Healthy Indiana Plan and Hoosier Healthwise Contract
PR Newswire - Wed Jun 15, 7:00AM CDT
Centene Corporation (NYSE: CNC) announced today that its wholly-owned Indiana subsidiary, Managed Health Services (MHS), has been selected to begin contract negotiations with the Indiana Family & Social Services Administration to provide risk-based managed care services for enrollees in the Healthy Indiana Plan and Hoosier Healthwise programs. The new contract is expected to commence on January 1, 2017.
CNC: 68.48 (-0.96)

Final Reminder Re: Centene Corporation's 2016 Investor Day In New York City
PR Newswire - Fri Jun 10, 7:00AM CDT
Centene Corporation (NYSE: CNC) issued a final reminder today regarding its previously announced annual Investor Day. The event will be held on Friday, June 17, 2016, at the Pierre Hotel on East 61st Street in New York City. The meeting, which also will be webcast live, will begin promptly at 8:30 a.m. Eastern Time and end approximately at noon Eastern Time, with breakfast and registration beginning at 7:30 a.m. At the meeting, Centene's senior management team is expected to make remarks regarding the Company's performance and future prospects.
CNC: 68.48 (-0.96)

Centene Corporation Announces Pricing Of Notes
PR Newswire - Thu Jun 09, 4:23PM CDT
Centene Corporation (NYSE: CNC) ("Centene" or the "Company"

today announced that on June 9, 2016 it priced $500 million aggregate principal amount of its 4.75% Senior Notes due 2022 (the "Senior Notes"

, in a public offering made pursuant to a registration statement and a related preliminary prospectus supplement filed by Centene with the Securities and Exchange Commission ("SEC"

. The underwriters were led by Citigroup, Barclays, SunTrust Robinson Humphrey and Wells Fargo Securities, with Morgan Stanley, Evercore ISI, Fifth Third Securities, Regions Securities LLC and US Bancorp as the co-managers of the offering. The Senior Notes will be issued at a price to the public of 101.75% plus accrued interest from May 15, 2016 and bear interest at 4.75%, for a yield to maturity of 4.41%. The Senior Notes will be an additional issuance of, be fully fungible with, rank equally with, have the same CUSIP number as, and form a single series with Centene's $300 million 4.75% Senior Notes due 2022 issued on April 29, 2014 and $200 million 4.75% Senior Notes due 2022 issued on January 14, 2015. The offering is expected to close on or about June 14, 2016. The issuance of the Senior Notes will be subject to customary closing conditions.
CNC: 68.48 (-0.96), WFC: 47.63 (-0.18), MS: 27.98 (-0.52)

Centene Corporation Announces Offering Of Notes
PR Newswire - Thu Jun 09, 6:26AM CDT
Centene Corporation (NYSE: CNC) ("Centene" or the "Company"

today announced that it has commenced an offering of approximately $500 million aggregate principal amount of 4.75% Senior Notes (the "Senior Notes"

due 2022 through underwriters led by Citigroup, Barclays, SunTrust Robinson Humphrey, and Wells Fargo Securities. Morgan Stanley, Evercore ISI, Fifth Third Securities, Regions Securities LLC and US Bancorp will be the co-managers of the offering. The Senior Notes are expected to be an additional issuance of, be fully fungible with, rank equally with, have the same CUSIP number as, and form a single series with Centene's $300 million 4.75% Senior Notes due 2022 issued on April 29, 2014 and $200 million 4.75% Senior Notes due 2022 issued on January 9, 2015. The offering is being conducted pursuant to a registration statement filed with the Securities and Exchange Commission (the "SEC"

.
CNC: 68.48 (-0.96), MS: 27.98 (-0.52)

SmarTrend Watching for Potential Pullback in Shares of Centene After 2.16% Gain
Comtex SmarTrend(R) - Wed Jun 08, 2:44PM CDT
Centene (NYSE:CNC) traded in a range yesterday that spanned from a low of $66.46 to a high of $68.11. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $66.86 on volume of 649,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CNC: 68.48 (-0.96)

Centene Corporation To Present At Barclays High Yield Bond & Syndicated Loan Conference
PR Newswire - Tue Jun 07, 3:30PM CDT
Centene Corporation (NYSE: CNC) announced today it will present at the Barclays High Yield Bond & Syndicated Loan Conference, to be held June 8-10, 2016, at The Broadmoor in Colorado Springs.
CNC: 68.48 (-0.96)

Centene Set to Possibly Pullback After Yesterday's Rally of 1.60%
Comtex SmarTrend(R) - Thu Jun 02, 1:20PM CDT
Centene (NYSE:CNC) traded in a range yesterday that spanned from a low of $62.91 to a high of $64.55. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $63.34 on volume of 779,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CNC: 68.48 (-0.96)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Melrose Fire Station Reaches Steel Topping Milestone

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Salveo Home Care Faces Class Action Over Labor Violations

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Quay Shines in 2026 Prescription Sunglasses Lineup

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Fuse Oncology Showcases New iRT Workflow at ASTRO

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...